Want to see JP:2395 full AI Analyst Report?
Shin Nippon Biomedical Laboratories, Ltd. (2395) Income Statement
Shin Nippon Biomedical Laboratories, Ltd. Income Statement
Last quarter (Q1 2026), Shin Nippon Biomedical Laboratories, Ltd.'s total revenue was $7.87B, an increase of 21.48% from the same quarter last year. In Q1, Shin Nippon Biomedical Laboratories, Ltd.'s net income was $1.06B. See Shin Nippon Biomedical Laboratories, Ltd.’s key income statements, including revenue, expenses, profit, and income.
| Income Statement | Mar 26 | Mar 25 | Mar 24 | Mar 23 | Mar 22 |
|---|---|---|---|---|---|
| $ 32.52B | $ 32.41B | $ 26.45B | $ 25.09B | $ 17.75B | |
| $ 15.83B | $ 16.57B | $ 14.28B | $ 13.05B | $ 9.69B | |
| $ 13.17B | $ 13.59B | $ 10.12B | $ 7.80B | $ 5.49B | |
| Depreciation and Amortization | $ 3.43B | $ 2.61B | $ 1.87B | $ 1.60B | $ 1.18B |
| $ 6.09B | $ 8.83B | $ 8.98B | $ 9.49B | $ 9.49B | |
| $ 2.65B | $ 2.99B | $ 4.16B | $ 5.25B | $ 4.20B | |
| $ 3.59B | $ 3.03B | $ 2.81B | $ 2.51B | $ 3.99B | |
| $ 6.25B | $ 6.01B | $ 6.97B | $ 7.76B | $ 8.18B | |
| $ 4.57B | $ 4.92B | $ 5.53B | $ 6.06B | $ 7.13B | |
| Per Share Metrics | |||||
| Basic EPS | $ 109.69 | $ 118.30 | $ 132.86 | $ 145.57 | $ 171.21 |
| Diluted EPS | $ 109.69 | $ 118.30 | $ 132.86 | $ 145.57 | $ 171.21 |
| Weighted Average Shares Outstanding | 41.63M | 41.63M | 41.63M | 41.63M | 41.63M |
| Weighted Average Shares Outstanding (Diluted) | 41.63M | 41.63M | 41.63M | 41.63M | 41.63M |
Currency in JPY
